Recent Finacing
Recent Raise
Tethys Bioscience develops the PreDx™ Diabetes Risk Score, a multimarker blood test that identifies patients at highest five-year risk of type 2 diabetes to inform clinical intervention decisions.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors